Twitter
youtube
Discord
Contact us
Forums
New posts
Trending
Rules
Explore
Bioenergetic Wiki
Bioenergetic Life Search
Bioprovement Peat Search
Ray Peat Interviews by Danny Roddy
Master List: Ray Peat, PhD Interviews & Quotes by FPS
Traveling Resources
Google Flights
Wiki Voyage
DeepL Translator
Niche
Numbeo
Merch
Log in
Register
What's new
Search
Search
Search engine:
Threadloom Search
XenForo Search
Search titles only
By:
New posts
Trending
Menu
Log in
Register
Navigation
Install the app
Install
More options
Light/Dark Mode
Contact us
Close Menu
Information
World News
Pfizer asks EU drug regulator to OK tweaked COVID vaccine
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="WPLG" data-source="post: 67966" data-attributes="member: 158"><p>Pfizer and BioNTech have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants.</p><p></p><p>In a statement Friday, Pfizer said it is requesting that the EU drug regulator OK its combination COVID-19 vaccine that targets the original coronavirus and BA.4 and BA.5, the latest versions of omicron, which are causing the vast majority of infections globally now. Pfizer and BioNTech are asking that the vaccine be given the green light for people aged 12 and over.</p><p></p><p>The European Medicines Agency is currently reviewing whether to clear updated versions of vaccines made by Moderna and Pfizer that target the subvariant BA.1, an earlier version of the virus that has since been overtaken by BA.4 and BA.5; that decision is expected next week.</p><p></p><p>If both of Pfizer's updated COVID-19 boosters are authorized, the company said its adapted vaccines would be available in Europe “as early as September.”</p><p></p><p>Last week, the <a href="https://apnews.com/article/covid-health-bbda6ba6107b3c839e42925136007fed" target="_blank">U.K. cleared Moderna's updated COVID-19 booster</a> targeting the BA.1 version of omicron and said it would be included in the country's vaccination campaign for people aged 50 and over beginning next month.</p><p></p><p><a href="https://apnews.com/article/covid-science-health-cd39872e31c490cb92c7678a8de83499" target="_blank">Pfizer and rival Moderna both asked U.S. regulators this week</a> to authorize modified versions of their booster vaccine — shots that are half the original recipe and half protection against BA.4 and BA.5.</p><p></p><p>Health authorities hope that the tweaked boosters might blunt the expected surge of COVID-19 this winter, but it's still unclear how effective they might be. The gamble is that BA.5, or something similar, still will be circulating this the winter and that immunization with these latest vaccines will still offer significant protection.</p><p></p><p>___</p><p></p><p>Follow all AP stories on the pandemic at <a href="https://apnews.com/hub/coronavirus-pandemic" target="_blank">https://apnews.com/hub/coronavirus-pandemic.</a></p><p></p><p><a href="https://www.local10.com/business/2022/08/26/pfizer-asks-eu-drug-regulator-to-ok-tweaked-covid-vaccine/" target="_blank">Continue reading...</a></p></blockquote><p></p>
[QUOTE="WPLG, post: 67966, member: 158"] Pfizer and BioNTech have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants. In a statement Friday, Pfizer said it is requesting that the EU drug regulator OK its combination COVID-19 vaccine that targets the original coronavirus and BA.4 and BA.5, the latest versions of omicron, which are causing the vast majority of infections globally now. Pfizer and BioNTech are asking that the vaccine be given the green light for people aged 12 and over. The European Medicines Agency is currently reviewing whether to clear updated versions of vaccines made by Moderna and Pfizer that target the subvariant BA.1, an earlier version of the virus that has since been overtaken by BA.4 and BA.5; that decision is expected next week. If both of Pfizer's updated COVID-19 boosters are authorized, the company said its adapted vaccines would be available in Europe “as early as September.” Last week, the [URL='https://apnews.com/article/covid-health-bbda6ba6107b3c839e42925136007fed']U.K. cleared Moderna's updated COVID-19 booster[/URL] targeting the BA.1 version of omicron and said it would be included in the country's vaccination campaign for people aged 50 and over beginning next month. [URL='https://apnews.com/article/covid-science-health-cd39872e31c490cb92c7678a8de83499']Pfizer and rival Moderna both asked U.S. regulators this week[/URL] to authorize modified versions of their booster vaccine — shots that are half the original recipe and half protection against BA.4 and BA.5. Health authorities hope that the tweaked boosters might blunt the expected surge of COVID-19 this winter, but it's still unclear how effective they might be. The gamble is that BA.5, or something similar, still will be circulating this the winter and that immunization with these latest vaccines will still offer significant protection. ___ Follow all AP stories on the pandemic at [URL='https://apnews.com/hub/coronavirus-pandemic']https://apnews.com/hub/coronavirus-pandemic.[/URL] [url="https://www.local10.com/business/2022/08/26/pfizer-asks-eu-drug-regulator-to-ok-tweaked-covid-vaccine/"]Continue reading...[/url] [/QUOTE]
Loading…
Insert quotes…
Verification
Post reply
Information
World News
Pfizer asks EU drug regulator to OK tweaked COVID vaccine
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top